Miramar, Fla. – October 2, 2017 – ImmunoSite Technologies, LLC, a leading global provider of contract R&D services, upgrades their dual ISO certifications from American Global Standard to the new standards as another step in their commitment to quality and customer service. ImmunoSite Technologies Automation Services are concentrated on fulfilling the special needs of life […]
Biomarker data from Astra Zeneca demonstrates that biomarkers enhance success in every aspect (safety, dosing, efficacy, patient selection) of every state of the drug development process.
ImmunoSite Technologies, LLC receives the 2013 Innovative Business award
02/01/2014. ImmunoSite Technologies was certified as a National MBE, Minority Business Enterprise, by the Southern Florida Minority Supplier Development Council as defined by the U.S. National Minority Supplier Development Council. The NMSDC was chartered in 1972 and is one of the country’s leading corporate membership organizations to advance business opportunities for certified business enterprises of all […]
Advanced automation of PBMC freezing (cryopreservation) and cell thawing improved the quantity and quality of PBMC yields and viability. through a partnership between ImmunoSite Technologies and MéCour.
Bill Malone wrote a great article for Clinical laboratory News (American Assoc for Clinical Chemistry) that goes straight to the heart of the folklore and myth surrounding the use of automation in laboratories. Check out “Blood, Sweat, and Robots.” Share this:
Press Release, February 28, 2013 ImmunoSite Technologies, LLC (IST), a provider of automation, design and customization of complex biological assays to biotechnology and pharmaceutical industries worldwide, announced its relocation to a newly expanded facility at 2831 Corporate Way in Miramar. With the expansion, the company will be retaining its current employees, making a capital investment […]
Executives, Engineers, and Scientists from ImmunoSite Technologies attended the Annual 2013 SLAS meeting in Orlando, Florida and brought back some of the latest technologies to integrate into new automated solutions for biological assay automation that will enhance their client’s productivity even more! Call IST to discuss your automation needs at (888) 770-4478 Share this:
Cell Culture Course helps Floridians enter, remain and advance in the workforce Fort Lauderdale, Fla. – October 18, 2011 – ImmunoSite Technologies (IST), LLC, a leading provider of immune monitoring services, has helped to develop a Cell Culture Workshop that is offered at the Employ Florida Banner Center for Life Sciences, based at Palm Beach […]
The need to implement robust biomarkers in clinical trials has never been greater, and such efforts can be easily compromised by reagent instability or simple human error during assay set-up. Many biotechnology and pharmaceutical companies are introducing efforts to conduct biomarker studies under more rigorous settings, and the use of plates or tubes pre-loaded with stimulation or staining reagents could be of value for studies that involve flow cytometry.
The value of this approach is that it lends itself to assay automation easily and safeguards against omission or erroneous addition of bulk liquid formulations of PMA and ionomycin to the reaction vessel (i.e., plate or tube) and also lends itself to extended stability/shelf-life of these reagents. On the basis of this initial success, we plan to expand our evaluation of lyophilized reagents so that they can be incorporated into our clinical biomarker campaigns as appropriate.
New Location Effective Dec. 2018
Mailing Address:
P.O. Box 165937
Miami, FL 33116, USA
Shipping Address:
4981 SW 74 Court
Miami, FL 33155, USA
(954) 462-6800
support@ist.us.com
IMMUNOSITE TECHNOLOGIES, LLC
P.O. Box 165937, Miami, FL 33116, USA
4981 SW 74 Court, Miami, FL 33155, USA
Telephone: (954) 462-6800
@2009 - 2018 ImmunoSite Technologies, LLC. All rights reserved.
